VERU INC. Stock-Based Compensation
VERU INC. (VERU) reported Stock-Based Compensation of $1.74 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-10
- VERU INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $577.97K, a 65.38% decline year-over-year.
- VERU INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $402.71K, a 81.89% decline year-over-year.
- VERU INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $757.61K, a 71.67% decline year-over-year.
- VERU INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $1.53M, a 52.44% decline year-over-year.
- VERU INC. share-based payment arrangement, noncash expense for fiscal 2025 was $8.10M, a 40.62% decline from fiscal 2024.
- VERU INC. share-based payment arrangement, noncash expense for fiscal 2024 was $13.64M, a 23.85% decline from fiscal 2023.
- VERU INC. share-based payment arrangement, noncash expense for fiscal 2023 was $17.92M, a 59.38% increase from fiscal 2022.
- VERU INC. share-based payment arrangement, noncash expense for fiscal 2022 was $11.24M, a 122.61% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $577.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-10 | $980.68K derived: sum of 2 quarters · filed 2026-08-10 | $1.74M 10-Q · filed 2026-08-10 | $3.27M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2026-03-31 | $402.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | $1.16M 10-Q · filed 2026-05-13 | $2.70M derived: sum of 3 quarters · filed 2026-05-13 | $4.36M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-12-31 | $757.61K 10-Q · filed 2026-02-11 | $2.29M derived: sum of 2 quarters · filed 2026-02-11 | $3.96M derived: sum of 3 quarters · filed 2026-08-10 | $6.19M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-09-30 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $3.20M derived: sum of 2 quarters · filed 2026-08-10 | $5.43M derived: sum of 3 quarters · filed 2026-08-10 | $8.10M 10-K · filed 2025-12-17 | |
| 2025-06-30 | $1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-10 | $3.89M derived: sum of 2 quarters · filed 2026-08-10 | $6.57M 10-Q · filed 2026-08-10 | $9.79M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-03-31 | $2.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | $4.90M 10-Q · filed 2026-05-13 | $8.12M derived: sum of 3 quarters · filed 2026-05-13 | $11.50M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $2.67M 10-Q · filed 2026-02-11 | $5.90M derived: sum of 2 quarters · filed 2026-02-11 | $9.28M derived: sum of 3 quarters · filed 2026-02-11 | $12.91M derived: sum of 4 quarters · filed 2026-02-11 | |
| 2024-09-30 | $3.23M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $6.60M derived: sum of 2 quarters · filed 2025-12-17 | $10.24M derived: sum of 3 quarters · filed 2025-12-17 | $13.64M 10-K · filed 2025-12-17 | |
| 2024-06-30 | $3.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-12 | $7.01M derived: sum of 2 quarters · filed 2025-08-12 | $10.42M 10-Q · filed 2025-08-12 | $15.10M derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | $3.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-08 | $7.04M 10-Q · filed 2025-05-08 | $11.73M derived: sum of 3 quarters · filed 2025-05-08 | $16.28M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | $3.41M 10-Q · filed 2025-02-13 | $8.09M derived: sum of 2 quarters · filed 2025-02-13 | $12.64M derived: sum of 3 quarters · filed 2025-02-13 | $16.48M derived: sum of 4 quarters · filed 2025-02-13 | |
| 2023-09-30 | $4.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-16 | $9.24M derived: sum of 2 quarters · filed 2024-12-16 | $13.07M derived: sum of 3 quarters · filed 2024-12-16 | $17.92M 10-K · filed 2024-12-16 | |
| 2023-06-30 | $4.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-08 | $8.39M derived: sum of 2 quarters · filed 2024-08-08 | $13.23M 10-Q · filed 2024-08-08 | $17.56M derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | $3.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-08 | $8.68M 10-Q · filed 2024-05-08 | $13.01M derived: sum of 3 quarters · filed 2024-05-08 | $15.92M derived: sum of 4 quarters · filed 2024-05-08 | |
| 2022-12-31 | $4.85M 10-Q · filed 2024-04-01 | $9.17M derived: sum of 2 quarters · filed 2024-04-01 | $12.08M derived: sum of 3 quarters · filed 2024-04-01 | $14.21M derived: sum of 4 quarters · filed 2024-04-01 | |
| 2022-09-30 | $4.33M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2024-04-01 | $7.24M derived: sum of 2 quarters · filed 2024-04-01 | $9.36M derived: sum of 3 quarters · filed 2024-04-01 | $11.24M 10-K/A · filed 2024-04-01 | |
| 2022-06-30 | $2.91M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2023-11-15 | $5.04M derived: sum of 2 quarters · filed 2023-11-15 | $6.92M 10-Q/A · filed 2023-11-15 | $8.28M derived: sum of 4 quarters · filed 2023-11-15 | |
| 2022-03-31 | $2.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-11 | $4.01M 10-Q · filed 2023-05-11 | $5.37M derived: sum of 3 quarters · filed 2023-05-11 | $7.27M derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $1.88M 10-Q · filed 2023-02-09 | $3.24M derived: sum of 2 quarters · filed 2023-02-09 | $5.14M derived: sum of 3 quarters · filed 2023-02-09 | $6.15M derived: sum of 4 quarters · filed 2023-02-09 | |
| 2021-09-30 | $1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-05 | $3.26M derived: sum of 2 quarters · filed 2022-12-05 | $4.27M derived: sum of 3 quarters · filed 2022-12-05 | $5.05M 10-K · filed 2022-12-05 | |
| 2021-06-30 | $1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-11 | $2.90M derived: sum of 2 quarters · filed 2022-08-11 | $3.69M 10-Q · filed 2022-08-11 | $4.35M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-12 | $1.79M 10-Q · filed 2022-05-12 | $2.45M derived: sum of 3 quarters · filed 2022-05-12 | $3.14M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $785.30K 10-Q · filed 2022-02-09 | $1.45M derived: sum of 2 quarters · filed 2022-02-09 | $2.14M derived: sum of 3 quarters · filed 2022-02-09 | $2.82M derived: sum of 4 quarters · filed 2022-02-09 | |
| 2020-09-30 | $664.75K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-02 | $1.35M derived: sum of 2 quarters · filed 2021-12-02 | $2.03M derived: sum of 3 quarters · filed 2021-12-02 | $2.65M 10-K · filed 2021-12-02 | |
| 2020-06-30 | $685.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-12 | $1.37M derived: sum of 2 quarters · filed 2021-08-12 | $1.98M 10-Q · filed 2021-08-12 | $2.51M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $681.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-12 | $1.30M 10-Q · filed 2021-05-12 | $1.82M derived: sum of 3 quarters · filed 2021-05-12 | $2.29M derived: sum of 4 quarters · filed 2021-05-12 | |
| 2019-12-31 | $614.50K 10-Q · filed 2021-02-10 | $1.14M derived: sum of 2 quarters · filed 2021-02-10 | $1.61M derived: sum of 3 quarters · filed 2021-02-10 | $2.10M derived: sum of 4 quarters · filed 2021-02-10 | |
| 2019-09-30 | $524.43K derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-10 | $992.63K derived: sum of 2 quarters · filed 2020-12-10 | $1.49M derived: sum of 3 quarters · filed 2020-12-10 | $1.91M 10-K · filed 2020-12-10 | |
| 2019-06-30 | $468.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-13 | $964.42K derived: sum of 2 quarters · filed 2020-08-13 | $1.38M 10-Q · filed 2020-08-13 | $1.94M derived: sum of 4 quarters · filed 2020-08-13 | |
| 2019-03-31 | $496.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-13 | $913.47K 10-Q · filed 2020-05-13 | $1.47M derived: sum of 3 quarters · filed 2020-05-13 | $1.93M derived: sum of 4 quarters · filed 2020-05-13 | |
| 2018-12-31 | $417.26K 10-Q · filed 2020-02-12 | $976.49K derived: sum of 2 quarters · filed 2020-02-12 | $1.44M derived: sum of 3 quarters · filed 2020-02-12 | $1.85M derived: sum of 4 quarters · filed 2020-02-12 | |
| 2018-09-30 | $559.23K derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-12 | $1.02M derived: sum of 2 quarters · filed 2019-12-12 | $1.43M derived: sum of 3 quarters · filed 2019-12-12 | $1.64M 10-K · filed 2019-12-12 | |
| 2018-06-30 | $459.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-08 | $871.82K derived: sum of 2 quarters · filed 2019-08-08 | $1.08M 10-Q · filed 2019-08-08 | $1.31M derived: sum of 4 quarters · filed 2019-08-08 | |
| 2018-03-31 | $411.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-15 | $619.30K 10-Q · filed 2019-05-15 | $847.79K derived: sum of 3 quarters · filed 2019-05-15 | $953.11K derived: sum of 4 quarters · filed 2019-05-15 | |
| 2017-12-31 | $207.45K 10-Q · filed 2019-02-13 | $435.94K derived: sum of 2 quarters · filed 2019-02-13 | $541.26K derived: sum of 3 quarters · filed 2019-02-13 | $646.42K derived: sum of 4 quarters · filed 2019-02-13 | |
| 2017-09-30 | $228.49K derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-13 | $333.81K derived: sum of 2 quarters · filed 2018-12-13 | $438.96K derived: sum of 3 quarters · filed 2018-12-13 | $756.27K 10-K · filed 2018-12-13 | |
| 2017-06-30 | $105.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-14 | $210.47K derived: sum of 2 quarters · filed 2018-08-14 | $527.78K 10-Q · filed 2018-08-14 | $662.96K derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | $105.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-11 | $422.47K 10-Q · filed 2018-05-11 | $557.64K derived: sum of 3 quarters · filed 2018-05-11 | $668.23K derived: sum of 4 quarters · filed 2018-05-11 | |
| 2016-12-31 | $317.31K 10-Q · filed 2018-02-14 | $452.48K derived: sum of 2 quarters · filed 2018-02-14 | $563.07K derived: sum of 3 quarters · filed 2018-02-14 | $693.84K derived: sum of 4 quarters · filed 2018-02-14 | |
| 2016-09-30 | $135.17K derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-02 | $245.76K derived: sum of 2 quarters · filed 2018-01-02 | $376.53K derived: sum of 3 quarters · filed 2018-01-02 | $499.87K 10-K · filed 2018-01-02 | |
| 2016-06-30 | $110.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09 | $241.36K derived: sum of 2 quarters · filed 2017-08-09 | $364.70K 10-Q · filed 2017-08-09 | $311.67K derived: sum of 4 quarters · filed 2018-01-02 | |
| 2016-03-31 | $130.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-10 | $254.12K 10-Q · filed 2017-05-10 | $201.08K derived: sum of 3 quarters · filed 2018-01-02 | $363.65K derived: sum of 4 quarters · filed 2018-01-02 | |
| 2015-12-31 | $123.34K 10-Q · filed 2017-02-09 | $70.31K derived: sum of 2 quarters · filed 2018-01-02 | $232.88K derived: sum of 3 quarters · filed 2018-01-02 | $413.36K derived: sum of 4 quarters · filed 2018-01-02 | |
| 2015-09-30 | -$53.03K derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-02 | $109.53K derived: sum of 2 quarters · filed 2018-01-02 | $290.01K derived: sum of 3 quarters · filed 2018-01-02 | $489.69K 10-K · filed 2018-01-02 | |
| 2015-06-30 | $162.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-07-28 | $343.05K derived: sum of 2 quarters · filed 2016-07-28 | $542.72K 10-Q · filed 2016-07-28 | $784.85K derived: sum of 4 quarters · filed 2016-12-12 | |
| 2015-03-31 | $180.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-04-28 | $380.16K 10-Q · filed 2016-04-28 | $622.28K derived: sum of 3 quarters · filed 2016-12-12 | $834.62K derived: sum of 4 quarters · filed 2016-12-12 | |
| 2014-12-31 | $199.68K 10-Q · filed 2016-02-02 | $441.80K derived: sum of 2 quarters · filed 2016-12-12 | $654.13K derived: sum of 3 quarters · filed 2016-12-12 | $854.54K derived: sum of 4 quarters · filed 2016-12-12 | |
| 2014-09-30 | $242.12K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-12 | $454.46K derived: sum of 2 quarters · filed 2016-12-12 | $654.86K derived: sum of 3 quarters · filed 2016-12-12 | $858.62K 10-K · filed 2016-12-12 | |
| 2014-06-30 | $212.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-07-30 | $412.74K derived: sum of 2 quarters · filed 2015-07-30 | $616.49K 10-Q · filed 2015-07-30 | $770.56K derived: sum of 4 quarters · filed 2015-12-02 | |
| 2014-03-31 | $200.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-04-30 | $404.16K 10-Q · filed 2015-04-30 | $558.23K derived: sum of 3 quarters · filed 2015-12-02 | $738.42K derived: sum of 4 quarters · filed 2015-12-02 | |
| 2013-12-31 | $203.75K 10-Q · filed 2015-02-03 | $357.82K derived: sum of 2 quarters · filed 2015-12-02 | $538.01K derived: sum of 3 quarters · filed 2015-12-02 | $711.52K derived: sum of 4 quarters · filed 2015-12-02 | |
| 2013-09-30 | $154.07K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-02 | $334.26K derived: sum of 2 quarters · filed 2015-12-02 | $507.77K derived: sum of 3 quarters · filed 2015-12-02 | $727.61K 10-K · filed 2015-12-02 | |
| 2013-06-30 | $180.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-31 | $353.70K derived: sum of 2 quarters · filed 2014-07-31 | $573.54K 10-Q · filed 2014-07-31 | $759.90K derived: sum of 4 quarters · filed 2014-12-02 | |
| 2013-03-31 | $173.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-01 | $393.35K 10-Q · filed 2014-05-01 | $579.72K derived: sum of 3 quarters · filed 2014-12-02 | $783.87K derived: sum of 4 quarters · filed 2014-12-02 | |
| 2012-12-31 | $219.84K 10-Q · filed 2014-02-03 | $406.20K derived: sum of 2 quarters · filed 2014-12-02 | $610.35K derived: sum of 3 quarters · filed 2014-12-02 | $834.18K derived: sum of 4 quarters · filed 2014-12-02 | |
| 2012-09-30 | $186.37K derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-02 | $390.52K derived: sum of 2 quarters · filed 2014-12-02 | $614.34K derived: sum of 3 quarters · filed 2014-12-02 | $842.51K 10-K · filed 2014-12-02 | |
| 2012-06-30 | $204.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-01 | $427.98K derived: sum of 2 quarters · filed 2013-08-01 | $656.15K 10-Q · filed 2013-08-01 | $881.86K derived: sum of 4 quarters · filed 2013-12-03 | |
| 2012-03-31 | $223.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-02 | $452.00K 10-Q · filed 2013-05-02 | $677.71K derived: sum of 3 quarters · filed 2013-12-03 | $900.91K derived: sum of 4 quarters · filed 2013-12-03 | |
| 2011-12-31 | $228.17K 10-Q · filed 2013-01-30 | $453.88K derived: sum of 2 quarters · filed 2013-12-03 | $677.09K derived: sum of 3 quarters · filed 2013-12-03 | $887.40K derived: sum of 4 quarters · filed 2013-12-03 | |
| 2011-09-30 | $225.71K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-03 | $448.92K derived: sum of 2 quarters · filed 2013-12-03 | $659.23K derived: sum of 3 quarters · filed 2013-12-03 | $796.45K 10-K · filed 2013-12-03 | $806.58K 10-K · filed 2011-12-02 |
| 2011-06-30 | $223.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-07-31 | $433.52K derived: sum of 2 quarters · filed 2012-07-31 | $570.74K 10-Q · filed 2012-07-31 | $671.03K derived: sum of 4 quarters · filed 2012-12-04 | |
| 2011-03-31 | $210.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-01 | $347.54K 10-Q · filed 2012-05-01 | $447.82K derived: sum of 3 quarters · filed 2012-12-04 | ||
| 2010-12-31 | $137.22K 10-Q · filed 2012-01-31 | $237.51K derived: sum of 2 quarters · filed 2012-12-04 | |||
| 2010-09-30 | $100.29K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-04 | $471.81K 10-K · filed 2012-12-04 | $357.82K 10-K · filed 2011-12-02 | ||
| 2010-06-30 | $371.52K 10-Q · filed 2011-08-05 | ||||
| 2009-09-30 | $299.16K 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |